In last trading session, Pulmonx Corp (NASDAQ:LUNG) saw 2.98 million shares changing hands with its beta currently measuring 0.65. Company’s recent per share price level of $8.78 trading at $2.14 or 32.23% at ring of the bell on the day assigns it a market valuation of $346.70M. That closing price of LUNG’s stock is at a discount of -66.29% from its 52-week high price of $14.60 and is indicating a premium of 37.81% from its 52-week low price of $5.46.

For Pulmonx Corp (LUNG), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.67. Splitting up the data highlights that, out of 4 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.

Pulmonx Corp (NASDAQ:LUNG) trade information

Upright in the green during last session for gaining 32.23%, in the last five days LUNG remained trading in the green while hitting it’s week-highest on Thursday, 02/20/25 when the stock touched $8.78 price level, adding 6.3% to its value on the day. Pulmonx Corp’s shares saw a change of 29.31% in year-to-date performance and have moved 25.25% in past 5-day. Pulmonx Corp (NASDAQ:LUNG) showed a performance of 41.84% in past 30-days.

Wall Street analysts have assigned a consensus price target of 10 to the stock, which implies a rise of 12.2% to its current value. Analysts have been projecting 10 as a low price target for the stock while placing it at a high target of 10. It follows that stock’s current price would drop -13.9% in reaching the projected high whereas dropping to the targeted low would mean a loss of -13.9% for stock’s current value.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -19.80% during past 5 years. In 2025, company’s earnings growth rate is likely to be around -6.66% while estimates for its earnings growth in next 5 years are of 5.22%.

Pulmonx Corp (NASDAQ:LUNG)’s Major holders

PRIMECAP MANAGEMENT CO/CA/ is the top institutional holder at LUNG for having 5.71 million shares of worth $36.2 million. And as of 2024-06-30, it was holding 14.6622 of the company’s outstanding shares.

The second largest institutional holder is FMR LLC, which was holding about 5.28 million shares on 2024-06-30. The number of shares represents firm’s hold over 13.5609 of outstanding shares, having a total worth of $33.48 million.